retatrutide nonalcoholic steatohepatitis nash trial Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment retatrutide nonalcoholic fatty liver disease
Description
MeAgain gives that view in one place with five food logging methods, symptom tracking, the shot log, and a weight trend that is easier to read than a string of daily numbers
In March 2023 it was recommended for the treatment of obesity in specific circumstances
The platform is relatively new (launched June 2025), which explains the limited independent review presence
doi: 10.1073/pnas.1513004112
